
Pharmac to fund more cancer medicines
Pharmac is funding six more medicines for cancers and one for antibiotic resistant infections. The following medicines will be funded from 1 April 2025: nivolumab (branded as Opdivo) and ipilimumab (branded as Yervoy) for clear cell kidney cancer that has …